Lilly's US Bamlanivimab Contract Raises Difficult Allocation Considerations

Open red metal empty medicine cabinet hanging on a dark gray marble wall background
Availability of Lilly's antibody for COVID-19 will be limited • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access